Proteomic profiling of the dystrophin-deficient MDX heart reveals drastically altered levels of key metabolic and contractile proteins

Journal of Biomedicine and Biotechnology

Volumn 2010, Issue , 2010, Pages

  Lewis, Caroline ^a   Jockusch, Harald ^b   Ohlendieck, Kay ^a  

^a NATIONAL UNIVERSITY OF IRELAND   (Ireland)

^b BIELEFELD UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACTIN; ADENYLATE KINASE; CONTRACTILE PROTEIN; DYSTROPHIN; FATTY ACID BINDING PROTEIN; ISOCITRATE DEHYDROGENASE; LAMIN A; LAMIN C; MYOSIN LIGHT CHAIN; NUCLEOSIDE DIPHOSPHATE KINASE; PEROXIREDOXIN; PORIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE DEHYDROGENASE; TROPOMYOSIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CARDIOMYOPATHY; CELLULAR STRESS RESPONSE; CONTROLLED STUDY; CYTOSKELETON; DISEASE COURSE; DNA MODIFICATION; ENERGY METABOLISM; FLUORESCENCE ANALYSIS; GEL ELECTROPHORESIS; HEART MUSCLE METABOLISM; MALE; MASS SPECTROMETRY; MOUSE; MUSCULAR DYSTROPHY; NONHUMAN; PROTEIN EXPRESSION; PROTEOMICS; X CHROMOSOME LINKED MUSCULAR DYSTROPHIC MOUSE;

EID: 77953491510     PISSN: 11107243     EISSN: 11107251     Source Type: Journal    
DOI: 10.1155/2010/648501     Document Type: Article

References (75)

1. Koening M., Hoffman E. P., Bertelson C. J., Monaco A. P., Feener C., Kunkel L. M., Complete cloning of the Duchenne muscular dystrophy (DMD) cDNA and preliminary genomic organization of the DMD gene in normal and affected individuals Cell 1987 50 3 509 517
2. Hoffman E. P., Brown R. H. Jr., Kunkel L. M., Dystrophin: the protein product of the Duchenne muscular dystrophy locus Cell 1987 51 6 919 928
3. Bonilla E., Samitt C. E., Miranda A. F., Duchenne muscular dystrophy: deficiency of dystrophin at the muscle cell suface Cell 1988 54 4 447 452
4. Deconinck N., Dan B., Pathophysiology of Duchenne muscular dystrophy: current hypotheses Pediatric Neurology 2007 36 1 1 7
5. Dalkilic I., Kunkel L. M., Muscular dystrophies: genes to pathogenesis Current Opinion in Genetics and Development 2003 13 3 231 238
6. Ohlendieck K., Towards an understanding of the dystrophin-glycoprotein complex: linkage between the extracellular matrix and the membrane cytoskeleton in muscle fibers European Journal of Cell Biology 1996 69 1 1 10
7. Ervasti J. M., Dystrophin, its interactions with other proteins, and implications for muscular dystrophy Biochimica et Biophysica Acta 2007 1772 2 108 117
8. Ahn A. H., Kunkel L. M., The structural and functional diversity of dystrophin Nature Genetics 1993 3 4 283 291
9. Cohn R. D., Campbell K. P., Molecular basis of muscular dystrophies Muscle Nerve 2000 23 10 1456 1471
10. Batchelor C. L., Winder S. J., Sparks, signals and shock absorbers: how dystrophin loss causes muscular dystrophy Trends in Cell Biology 2006 16 4 198 205
11. Anderson J. L., Head S. I., Rae C., Morley J. W., Brain function in Duchenne muscular dystrophy Brain 2002 125 1 4 13
12. Connuck D. M., Sleeper L. A., Colan S. D., Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry American Heart Journal 2008 155 6 998 1005
13. Finsterer J., Stollberger C., The heart in human dystrophinopathies Cardiology 2003 99 1 1 19
14. Cox G. F., Kunkel L. M., Dystrophies and heart disease Current Opinion in Cardiology 1997 12 3 329 343
15. Muntoni F., Cardiomyopathy in muscular dystrophies Current Opinion in Neurology 2003 16 5 577 583
16. Sultan A., Fayaz M., Prevalence of cardiomyopathy in Duchenne and Becker's muscular dystrophy Journal of Ayub Medical College, Abbottabad 2008 20 2 7 13
17. McNally E. M., New approaches in the therapy of cardiomyopathy in muscular dystrophy Annual Review of Medicine 2007 58 1 75 88
18. Duan D., Challenges and opportunities in dystrophin-deficient cardiomyopathy gene therapy Human Molecular Genetics 2006 15 2 R253 R261
19. Townsend D. W., Yasuda S., Metzger J., Cardiomyopathy of Duchenne muscular dystrophy: pathogenesis and prospect of membrane sealants as a new therapeutic approach Expert Review of Cardiovascular Therapy 2007 5 1 99 109
20. Grounds M. D., Radley H. G., Lynch G. S., Nagaraju K., De Luca A., Towards developing standard operating procedures for pre-clinical testing in the MDX mouse model of Duchenne muscular dystrophy Neurobiology of Disease 2008 31 1 1 19
21. Sicinski P., Geng Y., Ryder-Cook A. S., Barnard E. A., Darlison M. G., Barnard P. J., The molecular basis of muscular dystrophy in the MDX mouse: a point mutation Science 1989 244 4912 1578 1580
22. Bridges L. R., The association of cardiac muscle necrosis and inflammation with the degenerative and persistent myopathy of MDX mice Journal of the Neurological Sciences 1986 72 2-3 147 157
23. Chu V., Otero J. M., Lopez O., Electrocardiographic findings in MDX mice: a cardiac phenotype of Duchenne muscular dystrophy Muscle and Nerve 2002 26 4 513 519
24. Quinlan J. G., Hahn H. S., Wong B. L., Lorenz J. N., Wenisch A. S., Levin L. S., Evolution of the MDX mouse cardiomyopathy: physiological and morphological findings Neuromuscular Disorders 2004 14 8-9 491 496
25. Khairallah M., Khairallah R., Young M. E., Dyck J. R. B., Petrof B. J., Des Rosiers C., Metabolic and signaling alterations in dystrophin-deficient hearts precede overt cardiomyopathy Journal of Molecular and Cellular Cardiology 2007 43 2 119 129
26. Yue Y., Li Z., Harper S. Q., Davisson R. L., Chamberlain J. S., Duan D., Microdystrophin gene therapy of cardiomyopathy restores dystrophin-glycoprotein complex and improves sarcolemma integrity in the MDX mouse heart Circulation 2003 108 13 1626 1632
27. Wehling-Henricks M., Jordan M. C., Roos K. P., Deng B., Tidball J. G., Cardiomyopathy in dystrophin-deficient hearts is prevented by expression of a neuronal nitric oxide synthase transgene in the myocardium Human Molecular Genetics 2005 14 14 1921 1933
28. Wu B., Moulton H. M., Iversen P. L., Effective rescue of dystrophin improves cardiac function in dystrophin-deficient mice by a modified morpholino oligomer Proceedings of the National Academy of Sciences of the United States of America 2008 105 39 14814 14819
29. Buyse G. M., Van der Mieren G., Erb M., Long-term blinded placebo-controlled study of SNT-MC17/idebenone in the dystrophin deficient MDX mouse: cardiac protection and improved exercise performance European Heart Journal 2009 30 1 116 124
30. Sapp J. L., Bobet J., Howlett S. E., Contractile properties of myocardium are altered in dystrophin-deficient MDX mice Journal of the Neurological Sciences 1996 142 1-2 17 24
31. Bia B. L., Cassidy P. J., Young M. E., Decreased myocardial nNOS, increased iNOS and abnormal ECGs in mouse models of duchenne muscular dystrophy Journal of Molecular and Cellular Cardiology 1999 31 10 1857 1862
32. Lohan J., Culligan K., Ohlendieck K., Deficiency in cardiac dystrophin affects the abundance of the -/ -dystroglycan complex Journal of Biomedicine and Biotechnology 2005 2005 1 28 36
33. Lohan J., Ohlendieck K., Drastic reduction in the luminal Ca2+ -binding proteins calsequestrin and sarcalumenin in dystrophin-deficient cardiac muscle Biochimica et Biophysica Acta 2004 1689 3 252 258
34. Fanchaouy M., Polakova E., Jung C., Ogrodnik J., Shirokova N., Niggli E., Pathways of abnormal stress-induced Ca2+ influx into dystrophic MDX cardiomyocytes Cell Calcium 2009 46 2 114 121
35. Lefaucheur J. P., Pastoret C., Sebille A., Phenotype of dystrophinopathy in old MDX mice Anatomical Record 1995 242 1 70 76
36. Nakamura A., Yoshida K., Takeda S., Dohi N., Ikeda S.-I., Progression of dystrophic features and activation of mitogen-activated protein kinases and calcineurin by physical exercise, in hearts of MDX mice FEBS Letters 2002 520 13 18 24
37. Spurney C. F., Knoblach S., Pistilli E. E., Nagaraju K., Martin G. R., Hoffman E. P., Dystrophin-deficient cardiomyopathy in mouse: expression of Nox4 and Lox are associated with fibrosis and altered functional parameters in the heart Neuromuscular Disorders 2008 18 5 371 381
38. de Hoog C. L., Mann M., Proteomics Annual Review of Genomics and Human. Genetics 2004 5 1 267 293
39. Viswanathan S., Unlu M., Minden J. S., Two-dimensional difference gel electrophoresis Nature Protocols 2006 1 3 1351 1358
40. Marouga R., David S., Hawkins E., The development of the DIGE system: 2D fluorescence difference gel analysis technology Analytical and Bioanalytical Chemistry 2005 382 3 669 678
41. Doran P., Gannon J., O'Connell K., Ohlendieck K., Proteomic profiling of animal models mimicking skeletal muscle disorders Proteomics 2007 1 9 1169 1184
42. Ge Y., Molloy M. P., Chamberlain J. S., Andrews P. C., Proteomic analysis of MDX skeletal muscle: great reduction of adenylate kinase 1 expression and enzymatic activity Proteomics 2003 3 10 1895 1903
43. Doran P., Dowling P., Lohan J., McDonnell K., Poetsch S., Ohlendieck K., Subproteomics analysis of Ca2+ -binding proteins demonstrates decreased calsequestrin expression in dystrophic mouse skeletal muscle European Journal of Biochemistry 2004 271 19 3943 3952
44. Doran P., Dowling P., Donoghue P., Buffini M., Ohlendieck K., Reduced expression of regucalcin in young and aged MDX diaphragm indicates abnormal cytosolic calcium handling in dystrophin-deficient muscle Biochimica et Biophysica Acta 2006 1764 4 773 785
45. Doran P., Martin G., Dowling P., Jockusch H., Ohlendieck K., Proteome analysis of the dystrophin-deficient MDX diaphragm reveals a drastic increase in the heat shock protein cvHSP Proteomics 2006 6 16 4610 4621
46. Gulston M. K., Rubtsov D. V., Atherton H. J., A combined metabolomic and proteomic investigation of the effects of a failure to express dystrophin in the mouse heart Journal of Proteome Research 2008 7 5 2069 2077
47. Bradford M. M., A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein dye binding Analytical Biochemistry 1976 72 1-2 248 254
48. Karp N. A., Lilley K. S., Maximising sensitivity for detecting changes in protein expression: experimental design using minimal CyDyes Proteomics 2005 5 12 3105 3115
49. Doran P., O'Connell K., Gannon J., Kavanagh M., Ohlendieck K., Opposite pathobiochemical fate of pyruvate kinase and adenylate kinase in aged rat skeletal muscle as revealed by proteomic DIGE analysis Proteomics 2008 8 2 364 377
50. Rabilloud T., Strub J.-M., Luche S., van Dorsselaer A., Lunardi J., A comparison between Sypro Ruby and ruthenium II tris (bathophenanthroline disulfonate) as fluorescent stains for protein detection in gels Proteomics 2001 1 5 699 704
51. Shevchenko A., Tomas H., Havlis J., Olsen J. V., Mann M., In-gel digestion for mass spectrometric characterization of proteins and proteomes Nature Protocols 2006 1 6 2856 2860
52. Gannon J., Doran P., Kirwan A., Ohlendieck K., Drastic increase of myosin light chain MLC-2 in senescent skeletal muscle indicates fast-to-slow fibre transition in sarcopenia of old age European Journal of Cell Biology 2009 88 11 685 700
53. Poot M., Zhang Y.-Z., Kraemer J. A., Analysis of mitochondrial morphology and function with novel fixable fluorescent stains Journal of Histochemistry and Cytochemistry 1996 44 12 1363 1372
54. Pendergrass W., Wolf N., Pool M., Efficacy of MitoTracker Green and CMXrosamine to measure changes in mitochondrial membrane potentials in living cells and tissues Cytometry A 2004 61 2 162 169
55. Chazotte B., Labeling mitochondria with fluorescent dyes for imaging Cold Spring Harbor Protocols 2009 4 6
56. Urfer W., Grzegorczyk M., Jung K., Statistics for proteomics: a review of tools for analyzing experimental data Proteomics 2006 6 2, supplement 48 55
57. Raddatz K., Albrecht D., Hochgraefe F., Hecker M., Gotthardt M., A proteome map of murine heart and skeletal muscle Proteomics 2008 8 9 1885 1897
58. Westbrook J. A., Wheeler J. X., Wait R., Welson S. Y., Dunn M. J., The human heart proteome: two-dimensional maps using narrow-range immobilised pH gradients Electrophoresis 2006 27 8 1547 1555
59. McGregor E., Dunn M. J., Proteomics of the heart: unraveling disease Circulation Research 2006 98 3 309 321
60. Doran P., Wilton S. D., Fletcher S., Ohlendieck K., Proteomic profiling of antisense-induced exon skipping reveals reversal of pathobiochemical abnormalities in dystrophic MDX diaphragm Proteomics 2009 9 3 671 685
61. Malhotra R., Mason P. K., Lamin A/C deficiency as a cause of familial dilated cardiomyopathy Current Opinion in Cardiology 2009 24 3 203 208
62. Kimura N., Shimada N., Fukuda M., Regulation of cellular functions by nucleoside diphosphate kinases in mammals Journal of Bioenergetics and Biomembranes 2000 32 3 309 315
63. Braun U., Paju K., Eimre M., Lack of dystrophin is associated with altered integration of the mitochondria and ATPases in slow-twitch muscle cells of MDX mice Biochimica et Biophysica Acta 2001 1505 2-3 258 270
64. Nagy N., Malik G., Fisher A. B., Das D. K., Targeted disruption of peroxiredoxin 6 gene renders the heart vulnerable to ischemia-reperfusion injury American Journal of Physiology 2006 291 6 H2636 H2640
65. Boluyt M. O., Brevick J. L., Rogers D. S., Randall M. J., Scalia A. F., Li Z. B., Changes in the rat heart proteome induced by exercise training: increased abundance of heat shock protein hsp20 Proteomics 2006 6 10 3154 3169
66. Fisher E. A., Lapierre L. R., Junkins R. D., McLeod R. S., The AAA-ATPase p97 facilitates degradation of apolipoprotein B by the ubiquitin-proteasome pathway Journal of Lipid Research 2008 49 10 2149 2160
67. Szczesna D., Regulatory light chains of striated muscle myosin. Structure, function and malfunction Current Drug TargetsCardiovascular Haematological Disorders 2003 3 2 187 197
68. Frey N., Richardson J. A., Olson E. N., Calsarcins, a novel family of sarcomeric calcineurin-binding proteins Proceedings of the National Academy of Sciences of the United States of America 2000 97 26 14632 14637
69. Lemieux H., Hoppel C. L., Mitochondria in the human heart Journal of Bioenergetics and Biomembranes 2009 41 2 99 106
70. Distler A. M., Kerner J., Hoppel C. L., Proteomics of mitochondrial inner and outer membranes Proteomics 2008 8 19 4066 4082
71. White M. Y., Edwards A. V. G., Cordwell S. J., Van Eyk J. E., Mitochondria: a mirror into cellular dysfunction in heart disease Proteomics 2008 2 6 845 861
72. Zhang W., ten Hove M., Schneider J. E., Abnormal cardiac morphology, function and energy metabolism in the dystrophic MDX mouse: an MRI and MRS study Journal of Molecular and Cellular Cardiology 2008 45 6 754 760
73. Swanson M. A., Usselman R. J., Frerman F. E., Eaton G. R., Eaton S. S., The iron-sulfur cluster of electron transfer flavoprotein-ubiquinone oxidoreductase is the electron acceptor for electron transfer flavoprotein Biochemistry 2008 47 34 8894 8901
74. Liu X. H., Qian L. J., Gong J. B., Shen J., Zhang X. M., Qian X. H., Proteomic analysis of mitochondrial proteins in cardiomyocytes from chronic stressed rat Proteomics 2004 4 10 3167 3176
75. De Pinto V., Reina S., Guarino F., Messina A., Structure of the voltage dependent anion channel: state of the art Journal of Bioenergetics and Biomembranes 2008 40 3 139 147